 Connection
Rajesh Agarwal to Hyperlipoproteinemia Type II
This is a "connection" page, showing publications Rajesh Agarwal has written about Hyperlipoproteinemia Type II.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.168 |
|
|
|
-
Puri R, Mehta V, Duell PB, Nair D, Mohan JC, Yusuf J, Dalal JJ, Mishra S, Kasliwal RR, Agarwal R, Mukhopadhyay S, Wardhan H, Khanna NN, Pradhan A, Mehrotra R, Kumar A, Puri S, Muruganathan A, Sattur GB, Yadav M, Singh HP, Agarwal RK, Nanda R. Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: Expert consensus statement from Lipid Association of India. J Clin Lipidol. 2020 Mar - Apr; 14(2):e1-e13.
Score: 0.168
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|